CNS Pharmaceuticals’ $3 Million Common Stock Offering

ArentFox Schiff advised CNS Pharmaceuticals, while Sullivan & Worcester advised A.G.P./Alliance Global Partners on the offering.CNS Pharmaceuticals, Inc. closed the $3 million registered direct offering of…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here